PVG.L Regulatory News (PVG)

9 Feb 2006 11:18

Ark Therapeutics Group PLC09 February 2006 9 February 2006 Ark Therapeutics Group plc Director's Share Dealing Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that itwas informed today that Merlin Ventures Limited, as trustee of a FundedUnapproved Retirement Benefit Scheme in which Mr Peter Keen, a Non-ExecutiveDirector of Ark, is a beneficiary, on 7 February 2006 transferred the legalownership of 159,700 ordinary Ark shares of 1 pence each to new trustees,including Mr Keen. No consideration was paid in respect of the transfer.Following this transaction, Mr Keen is interested in 159,700 ordinary shares,representing 0.13% of the Company's issued share capital. - Ends - This information is provided by RNS The company news service from the London Stock Exchange